Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MDCX will rise by +76.71% over the next 2 Weeks and hit $0.68 by Friday, March 20, 2026. In that time frame, MDCX's share price is expected to range between $0.60 and $0.76.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 20, 2026 | 0.60 | 0.68 | 0.76 |
| Mar 19, 2026 | 0.54 | 0.62 | 0.70 |
| Mar 18, 2026 | 0.51 | 0.59 | 0.66 |
| Mar 17, 2026 | 0.50 | 0.58 | 0.65 |
| Mar 16, 2026 | 0.49 | 0.56 | 0.64 |
| Mar 13, 2026 | 0.46 | 0.54 | 0.61 |
| Mar 12, 2026 | 0.40 | 0.47 | 0.54 |
| Mar 11, 2026 | 0.37 | 0.44 | 0.50 |
| Mar 10, 2026 | 0.36 | 0.43 | 0.50 |
| Mar 9, 2026 | 0.35 | 0.42 | 0.49 |
MDCX shares fell -42.87% in Friday, March 6, 2026's trading session, dropping from a previous close of $0.68 to move at $0.39. The stock demonstrated notable intraday movement (see MDCX's key stats for a full breakdown), fluctuating between $0.37 and $0.60, a +61.89% trading range. While recent weeks have seen some volatility, MDCX has managed to secure a -64.79% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 16.1M shares changing hands, 14.13M more than the previous session. This amounted to $6.23M in total market activity.
Will MDCX Continue Its Upward Trend?
According to analyst ratings and projections for MDCX, Medicus Pharma Ltd. Common Stock shares are anticipated to increase by +49.13%, potentially reaching $0.76 per share by March 20, 2026. Short-term technical indicators currently suggest a bullish sentiment for MDCX. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the MDCX stock forecast, now is a good time to buy MDCX stock because its current trading price is -43.41% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MDCX covering social and institutional perspectives.
MDCX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MDCX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 20.09% to 27.71%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.36%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 42.81%, maintains a neutral outlook for the long term. Insights into MDCX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Medicus Pharma Common Stock Short-Term Forecasts
MDCX Forecast For Next 5 Days
Our algorithm anticipates Medicus Pharma Common Stock (MDCX) stock could hit $0.86 by Mar 13, 2026. This represents a +120.76% fall from today's price, following a -6.16% change over the past five days.
MDCX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Medicus Pharma Ltd. Common Stock (MDCX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.89, which would mean a +129.80% increase from the current price of $0.39. Projections for this period range from a high of $1.32 to a low of $0.53.
MDCX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Medicus Pharma Common Stock's price over the next three months point to a drop. MDCX stock is expected to peak at $1.46 on Mar 13, 2026 before potentially dipping to $0.00 on Jun 05, 2026. On average, MDCX is likely to trade around $0.33 in the coming 90 days.
Medicus Pharma Common Stock Stock Forecast 2025
Based on our predictive models, Medicus Pharma Common Stock (MDCX) is expected to trade between $0.00 and $1.46 throughout 2026. This would result in an average price of $0.36, potentially offering investors a -7.05% return from current levels.
Medicus Pharma Ltd. Common Stock Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in March 2026. The price is predicted to move between $0.00 and $1.46, settling at an average of $0.65. This could translate to a +67.83% gain.
April 2026
Based on current market signals, Medicus Pharma Ltd. Common Stock is projected to trend april 2026. We forecast a trading range from $0.00 to $0.90, with a likely average price of $0.31. Investors could expect a potential return of -19.96%.
May 2026
Our predictive algorithms indicate Medicus Pharma Ltd. Common Stock stock may see a shift in May 2026. The expected range spans $0.00–$0.68, with an average target of $0.18. This represents a cautious outlook and a possible loss of -53.52%.
June 2026
Analyzing established trends, Medicus Pharma Ltd. Common Stock looks set to move in June 2026. Projections place the stock between $0.00 and $0.00, averaging around $0.00. This suggests a -100.00% loss from current levels.
July 2026
Market indicators suggest Medicus Pharma Ltd. Common Stock could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $0.31, with a midpoint forecast of $0.05. The stock might deliver a -87.09% loss.
August 2026
Forecasting for August 2026, models estimate that Medicus Pharma Ltd. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.53, averaging $0.18. This signals a cautious trajectory with potential returns around -53.52%.
September 2026
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $0.60, settling at an average of $0.44. This could translate to a +13.61% gain.
October 2026
Based on current market signals, Medicus Pharma Ltd. Common Stock is projected to trend october 2026. We forecast a trading range from $0.00 to $0.55, with a likely average price of $0.58. Investors could expect a potential return of +49.75%.
November 2026
Our predictive algorithms indicate Medicus Pharma Ltd. Common Stock stock may see a shift in November 2026. The expected range spans $0.00–$0.39, with an average target of $0.73. This represents a positive outlook and a possible gain of +88.48%.
December 2026
Analyzing established trends, Medicus Pharma Ltd. Common Stock looks set to move in December 2026. Projections place the stock between $0.00 and $0.11, averaging around $0.56. This suggests a +44.59% gain from current levels.
January 2027
Market indicators suggest Medicus Pharma Ltd. Common Stock could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.03, with a midpoint forecast of $0.43. The stock might deliver a +11.03% gain.
February 2027
Forecasting for February 2027, models estimate that Medicus Pharma Ltd. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.27. This signals a cautious trajectory with potential returns around -30.29%.
March 2027
According to our latest forecast models, Medicus Pharma Ltd. Common Stock (MDCX) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.24. This could translate to a -38.03% loss.
MDCX's history of dividends and stock splits also plays a role in long-term investor confidence.

